Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch LLP | PRODUCT CODE: 1201374

Cover Image

PUBLISHER: 360iResearch LLP | PRODUCT CODE: 1201374

COVID-19 Testing Market Research Report by Kit Type, Test Type, Specimen Type, Application, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, High Inflation - Global Forecast 2023-2030

PUBLISHED:
PAGES: 244 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
Online Access - 1 Year (Single User License)
USD 3949
PDF & Excel + Online Access - 1 Year (Single User License)
USD 4949
PDF & Excel + Online Access - 1 Year (Up to 5 User License)
USD 5949
PDF & Excel + Online Access - 1 Year (Site License)
USD 6949
PDF & Excel + Online Access - 1 Year (Enterprise User License)
USD 8949

Add to Cart

Contact us about how to customize the report with add-on data.

The Global COVID-19 Testing Market size was estimated at USD 35.42 billion in 2022 and expected to reach USD 38.84 billion in 2023, projecting growth at a CAGR of 10.13% to reach USD 76.69 billion by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global COVID-19 Testing Market.

Cumulative Impact of Russia-Ukraine Conflict:

We continuously monitor and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people's lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global COVID-19 Testing Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global COVID-19 Testing Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global COVID-19 Testing Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the Global COVID-19 Testing Market in order to forecast the revenues and analyze the trends in each of the following sub-markets.

Based on Kit Type, the market is studied across Rapid Test Kit and Real-Time Reverse Transcription Polymerase Chain Reaction (RT-PCR).

Based on Test Type, the market is studied across Multiplex NAATs, NAAT Point of Care, and Singleplex Nucleic Acid Amplification Tests.

Based on Specimen Type, the market is studied across Blood, Nasal Swab, Nasopharyngeal Swab, Oropharyngeal Swab, and Urine.

Based on Application, the market is studied across Clinics, Diagnostic Centers, and Hospitals.

Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global COVID-19 Testing Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global COVID-19 Testing Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global COVID-19 Testing Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global COVID-19 Testing Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor's strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global COVID-19 Testing Market, including Abbott Laboratories, AccuBioTech Co. Ltd., ADT Biotech, AIVD Biotech Inc., Altona Diagnostics GmbH, AMEDA Labordiagnostik GmbH, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Cepheid Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Laboratory Corporation of America Holdings, Luminex Corporation, PerkinElmer Inc., Quest Diagnostics Inc., Quidel Corporation, Siemens Healthineers AG, and Thermo Fisher Scientific Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global COVID-19 Testing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global COVID-19 Testing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global COVID-19 Testing Market?

4. What is the competitive strategic window for opportunities in the Global COVID-19 Testing Market?

5. What are the technology trends and regulatory frameworks in the Global COVID-19 Testing Market?

6. What is the market share of the leading vendors in the Global COVID-19 Testing Market?

7. What modes and strategic moves are considered suitable for entering the Global COVID-19 Testing Market?

Product Code: MRR-02026C4C988F

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of COVID-19-infected patients globally
      • 5.1.1.2. Rising government initiatives toward the implementation of mass testing
      • 5.1.1.3. Increasing patient population globally and enormous need for speedy diagnostics
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of awareness among medical professionals about precautions
    • 5.1.3. Opportunities
      • 5.1.3.1. Focus of new entrants toward at-home testing and integration of advanced software
      • 5.1.3.2. Development and innovations in COVID-19 testing devices
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with scarcity of diagnostic kits
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Cumulative Impact of Russia-Ukraine Conflict
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Threat of Substitutes
    • 5.5.4. Threat of Substitutes
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework
  • 5.8. Client Customization

6. COVID-19 Testing Market, by Kit Type

  • 6.1. Introduction
  • 6.2. Rapid Test Kit
  • 6.3. Real-Time Reverse Transcription Polymerase Chain Reaction (RT-PCR)

7. COVID-19 Testing Market, by Test Type

  • 7.1. Introduction
  • 7.2. Multiplex NAATs
  • 7.3. NAAT Point of Care
  • 7.4. Singleplex Nucleic Acid Amplification Tests

8. COVID-19 Testing Market, by Specimen Type

  • 8.1. Introduction
  • 8.2. Blood
  • 8.3. Nasal Swab
  • 8.4. Nasopharyngeal Swab
  • 8.5. Oropharyngeal Swab
  • 8.6. Urine

9. COVID-19 Testing Market, by Application

  • 9.1. Introduction
  • 9.2. Clinics
  • 9.3. Diagnostic Centers
  • 9.4. Hospitals

10. Americas COVID-19 Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific COVID-19 Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa COVID-19 Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
    • 13.1.1. Quadrants
    • 13.1.2. Business Strategy
    • 13.1.3. Product Satisfaction
  • 13.2. Market Ranking Analysis, By Key Player
  • 13.3. Market Share Analysis, By Key Player
  • 13.4. Product Portfolio Analysis, By Key Player
  • 13.5. Competitive Scenario
    • 13.5.1. Merger & Acquisition
    • 13.5.2. Agreement, Collaboration, & Partnership
    • 13.5.3. New Product Launch & Enhancement
    • 13.5.4. Investment & Funding
    • 13.5.5. Award, Recognition, & Expansion

14. Company Usability Profiles

  • 14.1. Abbott Laboratories
  • 14.2. AccuBioTech Co. Ltd.
  • 14.3. ADT Biotech
  • 14.4. AIVD Biotech Inc.
  • 14.5. Altona Diagnostics GmbH
  • 14.6. AMEDA Labordiagnostik GmbH
  • 14.7. Becton, Dickinson and Company
  • 14.8. Bio-Rad Laboratories, Inc.
  • 14.9. bioMerieux SA
  • 14.10. Cepheid Inc.
  • 14.11. Danaher Corporation
  • 14.12. F. Hoffmann-La Roche AG
  • 14.13. Hologic Inc.
  • 14.14. Laboratory Corporation of America Holdings
  • 14.15. Luminex Corporation
  • 14.16. PerkinElmer Inc.
  • 14.17. Quest Diagnostics Inc.
  • 14.18. Quidel Corporation
  • 14.19. Siemens Healthineers AG
  • 14.20. Thermo Fisher Scientific Inc.

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing
Product Code: MRR-02026C4C988F

LIST OF FIGURES

  • FIGURE 1. GLOBAL COVID-19 TESTING MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL COVID-19 TESTING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. GLOBAL COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COVID-19 TESTING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. GLOBAL COVID-19 TESTING MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL COVID-19 TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
  • FIGURE 7. GLOBAL COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 8. GLOBAL COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL COVID-19 TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
  • FIGURE 10. GLOBAL COVID-19 TESTING MARKET DYNAMICS
  • FIGURE 11. GLOBAL COVID-19 TESTING MARKET PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 12. GLOBAL COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2022 VS 2030 (%)
  • FIGURE 13. GLOBAL COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL COVID-19 TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY KIT TYPE, 2030
  • FIGURE 15. GLOBAL COVID-19 TESTING MARKET SIZE, BY RAPID TEST KIT, 2018-2030 (USD MILLION)
  • FIGURE 16. GLOBAL COVID-19 TESTING MARKET SIZE, BY REAL-TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION (RT-PCR), 2018-2030 (USD MILLION)
  • FIGURE 17. GLOBAL COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2022 VS 2030 (%)
  • FIGURE 18. GLOBAL COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. GLOBAL COVID-19 TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY TEST TYPE, 2030
  • FIGURE 20. GLOBAL COVID-19 TESTING MARKET SIZE, BY MULTIPLEX NAATS, 2018-2030 (USD MILLION)
  • FIGURE 21. GLOBAL COVID-19 TESTING MARKET SIZE, BY NAAT POINT OF CARE, 2018-2030 (USD MILLION)
  • FIGURE 22. GLOBAL COVID-19 TESTING MARKET SIZE, BY SINGLEPLEX NUCLEIC ACID AMPLIFICATION TESTS , 2018-2030 (USD MILLION)
  • FIGURE 23. GLOBAL COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2022 VS 2030 (%)
  • FIGURE 24. GLOBAL COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 25. GLOBAL COVID-19 TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY SPECIMEN TYPE, 2030
  • FIGURE 26. GLOBAL COVID-19 TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
  • FIGURE 27. GLOBAL COVID-19 TESTING MARKET SIZE, BY NASAL SWAB, 2018-2030 (USD MILLION)
  • FIGURE 28. GLOBAL COVID-19 TESTING MARKET SIZE, BY NASOPHARYNGEAL SWAB, 2018-2030 (USD MILLION)
  • FIGURE 29. GLOBAL COVID-19 TESTING MARKET SIZE, BY OROPHARYNGEAL SWAB, 2018-2030 (USD MILLION)
  • FIGURE 30. GLOBAL COVID-19 TESTING MARKET SIZE, BY URINE, 2018-2030 (USD MILLION)
  • FIGURE 31. GLOBAL COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 32. GLOBAL COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 33. GLOBAL COVID-19 TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2030
  • FIGURE 34. GLOBAL COVID-19 TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • FIGURE 35. GLOBAL COVID-19 TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • FIGURE 36. GLOBAL COVID-19 TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • FIGURE 37. AMERICAS COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 38. AMERICAS COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 39. AMERICAS COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 40. AMERICAS COVID-19 TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
  • FIGURE 41. ARGENTINA COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 42. BRAZIL COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 43. CANADA COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 44. MEXICO COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 45. UNITED STATES COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 46. UNITED STATES COVID-19 TESTING MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 47. UNITED STATES COVID-19 TESTING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 48. UNITED STATES COVID-19 TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
  • FIGURE 49. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 50. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 51. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 52. ASIA-PACIFIC COVID-19 TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
  • FIGURE 53. AUSTRALIA COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 54. CHINA COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 55. INDIA COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 56. INDONESIA COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 57. JAPAN COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 58. MALAYSIA COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 59. PHILIPPINES COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 60. SINGAPORE COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 61. SOUTH KOREA COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 62. TAIWAN COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 63. THAILAND COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 64. VIETNAM COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 65. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 66. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 67. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 68. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
  • FIGURE 69. DENMARK COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 70. EGYPT COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 71. FINLAND COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 72. FRANCE COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 73. GERMANY COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 74. ISRAEL COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 75. ITALY COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 76. NETHERLANDS COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 77. NIGERIA COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 78. NORWAY COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 79. POLAND COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 80. QATAR COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 81. RUSSIA COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 82. SAUDI ARABIA COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 83. SOUTH AFRICA COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 84. SPAIN COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 85. SWEDEN COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 86. SWITZERLAND COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 87. TURKEY COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 88. UNITED ARAB EMIRATES COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 89. UNITED KINGDOM COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 90. GLOBAL COVID-19 TESTING MARKET: FPNV POSITIONING MATRIX, 2022
  • FIGURE 91. GLOBAL COVID-19 TESTING MARKET SHARE, BY KEY PLAYER, 2022
  • FIGURE 92. GLOBAL COVID-19 TESTING MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022

LIST OF TABLES

  • TABLE 1. GLOBAL COVID-19 TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. GLOBAL COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL COVID-19 TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GLOBAL COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 7. GLOBAL COVID-19 TESTING MARKET SIZE, BY RAPID TEST KIT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL COVID-19 TESTING MARKET SIZE, BY RAPID TEST KIT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL COVID-19 TESTING MARKET SIZE, BY RAPID TEST KIT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL COVID-19 TESTING MARKET SIZE, BY REAL-TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION (RT-PCR), 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL COVID-19 TESTING MARKET SIZE, BY REAL-TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION (RT-PCR), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL COVID-19 TESTING MARKET SIZE, BY REAL-TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION (RT-PCR), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL COVID-19 TESTING MARKET SIZE, BY MULTIPLEX NAATS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL COVID-19 TESTING MARKET SIZE, BY MULTIPLEX NAATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL COVID-19 TESTING MARKET SIZE, BY MULTIPLEX NAATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL COVID-19 TESTING MARKET SIZE, BY NAAT POINT OF CARE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL COVID-19 TESTING MARKET SIZE, BY NAAT POINT OF CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL COVID-19 TESTING MARKET SIZE, BY NAAT POINT OF CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL COVID-19 TESTING MARKET SIZE, BY SINGLEPLEX NUCLEIC ACID AMPLIFICATION TESTS , 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL COVID-19 TESTING MARKET SIZE, BY SINGLEPLEX NUCLEIC ACID AMPLIFICATION TESTS , BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL COVID-19 TESTING MARKET SIZE, BY SINGLEPLEX NUCLEIC ACID AMPLIFICATION TESTS , BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL COVID-19 TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL COVID-19 TESTING MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL COVID-19 TESTING MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL COVID-19 TESTING MARKET SIZE, BY NASAL SWAB, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL COVID-19 TESTING MARKET SIZE, BY NASAL SWAB, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL COVID-19 TESTING MARKET SIZE, BY NASAL SWAB, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL COVID-19 TESTING MARKET SIZE, BY NASOPHARYNGEAL SWAB, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL COVID-19 TESTING MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL COVID-19 TESTING MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL COVID-19 TESTING MARKET SIZE, BY OROPHARYNGEAL SWAB, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL COVID-19 TESTING MARKET SIZE, BY OROPHARYNGEAL SWAB, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL COVID-19 TESTING MARKET SIZE, BY OROPHARYNGEAL SWAB, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL COVID-19 TESTING MARKET SIZE, BY URINE, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL COVID-19 TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL COVID-19 TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL COVID-19 TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL COVID-19 TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL COVID-19 TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL COVID-19 TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL COVID-19 TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL COVID-19 TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL COVID-19 TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL COVID-19 TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL COVID-19 TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES COVID-19 TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. JAPAN COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. MALAYSIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. EGYPT COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. FINLAND COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 164. FINLAND COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. FRANCE COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 169. FRANCE COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. FRANCE COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. GERMANY COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 174. GERMANY COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. GERMANY COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. GERMANY COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. ISRAEL COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 179. ISRAEL COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. ISRAEL COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. ISRAEL COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. ISRAEL COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. ITALY COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 184. ITALY COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. ITALY COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. ITALY COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. ITALY COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. NETHERLANDS COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 189. NETHERLANDS COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. NETHERLANDS COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. NETHERLANDS COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. NETHERLANDS COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. NIGERIA COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 194. NIGERIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. NIGERIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. NIGERIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. NIGERIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. NORWAY COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 199. NORWAY COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. NORWAY COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. NORWAY COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. NORWAY COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. POLAND COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 204. POLAND COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. POLAND COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. POLAND COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. POLAND COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. QATAR COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 209. QATAR COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. QATAR COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. QATAR COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. QATAR COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. RUSSIA COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 214. RUSSIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. RUSSIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. RUSSIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. RUSSIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. SAUDI ARABIA COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 219. SAUDI ARABIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. SAUDI ARABIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. SAUDI ARABIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. SAUDI ARABIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. SOUTH AFRICA COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 224. SOUTH AFRICA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. SOUTH AFRICA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. SOUTH AFRICA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. SOUTH AFRICA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. SPAIN COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 229. SPAIN COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. SPAIN COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. SPAIN COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. SPAIN COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. SWEDEN COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 234. SWEDEN COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. SWEDEN COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. SWEDEN COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. SWEDEN COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. SWITZERLAND COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 239. SWITZERLAND COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. SWITZERLAND COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. SWITZERLAND COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. SWITZERLAND COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 243. TURKEY COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 244. TURKEY COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. TURKEY COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. TURKEY COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. TURKEY COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 248. UNITED ARAB EMIRATES COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 249. UNITED ARAB EMIRATES COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. UNITED ARAB EMIRATES COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. UNITED ARAB EMIRATES COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. UNITED ARAB EMIRATES COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. UNITED KINGDOM COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 254. UNITED KINGDOM COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. UNITED KINGDOM COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. UNITED KINGDOM COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. UNITED KINGDOM COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. GLOBAL COVID-19 TESTING MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
  • TABLE 259. GLOBAL COVID-19 TESTING MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
  • TABLE 260. GLOBAL COVID-19 TESTING MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
  • TABLE 261. GLOBAL COVID-19 TESTING MARKET RANKING, BY KEY PLAYER, 2022
  • TABLE 262. GLOBAL COVID-19 TESTING MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 263. GLOBAL COVID-19 TESTING MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
  • TABLE 264. GLOBAL COVID-19 TESTING MARKET MERGER & ACQUISITION
  • TABLE 265. GLOBAL COVID-19 TESTING MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 266. GLOBAL COVID-19 TESTING MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 267. GLOBAL COVID-19 TESTING MARKET INVESTMENT & FUNDING
  • TABLE 268. GLOBAL COVID-19 TESTING MARKET AWARD, RECOGNITION, & EXPANSION
  • TABLE 269. GLOBAL COVID-19 TESTING MARKET: LICENSE & PRICING
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!